EP Patent

EP2489389A1 — Detent mechanism

Assigned to Sanofi Aventis Deutschland GmbH · Expires 2012-08-22 · 14y expired

What this patent protects

The invention relates to a detent mechanism (18) for controlling translation between two components (2,7) in a longitudinal direction (P,D), the detent mechanism (18) comprising a resilient beam (2.1) and a rhomboid ramp member (7.1), the resilient beam (2.1) having a first beam …

USPTO Abstract

The invention relates to a detent mechanism (18) for controlling translation between two components (2,7) in a longitudinal direction (P,D), the detent mechanism (18) comprising a resilient beam (2.1) and a rhomboid ramp member (7.1), the resilient beam (2.1) having a first beam head (2.2) and arranged to interact in a ramped engagement with respectively one of two ramps (7.2,7.3), each ramp on one longitudinal side of the rhomboid ramp member (7.1) in such a manner that application of a translative force between the components (2,7) in one longitudinal direction (P,D) with the first beam head (2.2) engaged to one of the ramps (7.2,7.3) in a first state (A,C) deflects the resilient beam (2.1) in one transversal direction (O,I) when a predetermined value of the translative force, wherein the resilient beam (2.1) is allowed to relax when the first beam head (2.2) has reached the other one of the ramps (7.3,7.2) in a second state (C, A), wherein application of a translative force between the components (2,7) in the other longitudinal direction (D,P) with the first beam head (2.2) engaged to the other one of the ramps (7.3,7.2) deflects the resilient beam (2.1) in the other transversal direction (I,O) when a predetermined value of the translative force.

Drugs covered by this patent

Patent Metadata

Patent number
EP2489389A1
Jurisdiction
EP
Classification
Expires
2012-08-22
Drug substance claim
No
Drug product claim
No
Assignee
Sanofi Aventis Deutschland GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.